Post-marketing re-evaluation of Jiawei Xiaoyao Wan for premenstrual syndrome

Phase 4, randomised, double-blind trial of jia wei xiao yao san in premenstrual syndrome (PMS) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Change in luteal phase DRSP total score from baseline after 3 menstrual cycles and Change in TCM syndrome scores and individual TCM symptoms after 1, 2, and 3 menstrual cycles. Started Aug 2017; status: completed.